StevenMankowitzHorwitzMD

Pediatric Critical Care Medicine

Physician

Dr. Horwitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Robert Wood Johnson Pl
New Brunswick, NJ 08901
Phone+1 732-235-7887

Fax+1 732-235-6609

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Critical Care Medicine, 2011 - 2014
Westchester Medical CenterResidency, Pediatrics, 2008 - 2011
St. George's University School of MedicineClass of 2008

PubMed

56 citations
Non-Hodgkin's lymphomas, version 1.2013: Featured updates to the NCCN guidelines
Andrew D. Zelenetz, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis
Journal of the National Comprehensive Cancer Network. 2013-03-01
145 citations
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma.
Alison J. Moskowitz, Paul A. Hamlin, Miguel-Angel Perales, John F. Gerecitano, Steven M. Horwitz
Journal of Clinical Oncology. 2013-02-01
212 citations
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
Craig H. Moskowitz, Matthew J. Matasar, Andrew D. Zelenetz, Stephen D. Nimer, John F. Gerecitano
Blood. 2012-02-16

New Study May Offer Treatment Guidance for MIS-CJuly 12th, 2021
ADC Therapeutics Gibt Zwischenergebnisse Aus Phase-I-studie Zu Neuartigem AntiköRper-Wirkstoff-Konjugat ADCT-301 BekanntDecember 11th, 2017